Clinical Trials

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT02676349 2026-03-27

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Phase 2 Completed

130 enrolled

Pancreatic Neoplasms

NCT04503694 2026-03-27

REGINA

72 enrolled

Rectal Neoplasms

NCT06850103 2026-03-25

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

51 enrolled

Colorectal Neoplasms

NCT06258525 2026-03-18

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

NCT06269978 2026-03-10

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Phase 1 Recruiting

24 enrolled

Colorectal Neoplasms

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Advanced Biliary Tract Carcinoma

NCT06307548 2026-02-10

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Phase 1/2 Suspended

21 enrolled

Colorectal Neoplasms

NCT07162506 2026-02-04

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

120 enrolled

Phase 3 Not yet recruiting

Esophageal Neoplasms

NCT02448173 2026-02-02

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

550 enrolled

Colonic Neoplasms

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

2,000 enrolled

Esophageal Neoplasms

NCT06468280 2026-01-21

ROSETTE

84 enrolled

Stomach Neoplasms

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Phase 2 Enrolling by invitation

Esophageal Squamous Cell Carcinoma

NCT07139951 2025-12-31

HORIZON

16 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT03042169 2025-12-23

SURGIGAST

Phase 3 Terminated

6 enrolled

Stomach Neoplasms

NCT04587739 2025-12-23

KARCHER-1

Phase 1 Recruiting

Carcinoma, Hepatocellular

NCT06576921 2025-12-23

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

116 enrolled

Stomach Neoplasms

NCT07290764 2025-12-18

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy

Enrolling by invitation

729 enrolled

Carcinoma, Hepatocellular

NCT05836584 2025-12-01

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

240 enrolled

Phase NA Active not recruiting

Clinical Stage I Gastric Cancer AJCC v8

NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

2 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT06940947 2025-11-20

ETHOS

434 enrolled

Colonic Neoplasms

NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Phase 1 Terminated

4 enrolled

Pancreatic Neoplasms

NCT06994299 2025-11-18

PRISM

Phase 2 Withdrawn

Carcinoma, Hepatocellular

NCT04982653 2025-11-10

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

140 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

270 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

168 enrolled

Pancreatic Neoplasms

NCT07200141 2025-09-30

SIB-NCRT-pumch

156 enrolled

Locally Advanced Rectal Adenocarcinoma

NCT04809025 2025-09-29

EBPS

510 enrolled

Stomach Neoplasms

NCT07194616 2025-09-26

Rectal Cancer CTC Trial

Phase NA Recruiting

120 enrolled

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

60 enrolled

Colonic Neoplasms

NCT07183280 2025-09-19

SPN

2,000 enrolled

Solid Pseudopapillary Neoplasm of the Pancreas

NCT07162714 2025-09-09

STAR

Rectal Neoplasms

NCT05760404 2025-09-08

CB1 - CONTRACT

Completed

36 enrolled

Colorectal Neoplasms

NCT06574373 2025-09-03

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

3,600 enrolled

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT05265208 2025-08-06

SIROCHO

62 enrolled

Resectable Intrahepatic Cholangiocarcinoma

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

60 enrolled

Esophageal Neoplasms

NCT06476067 2025-07-11

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

150 enrolled

Esophageal Neoplasms, Recurrence

NCT04958720 2025-07-03

AGAMENON

10,000 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

50 enrolled

Esophageal Neoplasms, Esophagitis

NCT04404777 2025-06-17

LERIS

Active not recruiting

12,000 enrolled

Rectal Neoplasms

NCT06646445 2025-06-13

PREMICES

60 enrolled

Phase 2/3 Not yet recruiting

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT07000253 2025-06-02

OMEC-5

290 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06908031 2025-05-14

CRIT

49 enrolled

Phase NA Active not recruiting

Rectal Neoplasms

NCT01792934 2025-04-15

ORCHESTRA

478 enrolled

Multi-organ Metastatic Colorectal Cancer

NCT06919510 2025-04-09

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

90 enrolled

Rectal Neoplasms

NCT06898398 2025-04-03

TACE Combined Surgery for the Resectable Huge HCC

326 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06293625 2025-03-30

FOxTROT2France

150 enrolled

Colonic Neoplasms

NCT06246344 2025-03-12

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

128 enrolled